Nikkei Rally Continues
The recent breakout trade in the NIKKEI has now hit its final target at the 30502.8 level. The increasing optimism around rising vaccination rates in Japan has been a big contributing factor for the rally. This week, Japan passed the US in terms of the percentage of the population having received the first dose of the vaccine along with 51% of the country now being fully vaccinated. Along with this, there is fresh optimism around a potential political change in the upcoming elections after the current PM announced he will not be running for election. The PM’s main contender, Fushida, is calling for a sweeping new stimulus package which would support stocks. With this in mind, the outlook remains bullish for the Nikkei though there is room for correction in the near term given the velocity of the recent move.
Key Data to Watch
Little on the slate for Japan this week and so the main focus will be on US data and risk flows. Any data misses for the US should see the Nikkei continue higher, diluting near-term Fed tapering expectations. However, any data beats might see the Nikkei correct if USD sees any meaningful upside action.
Disclaimer: The material provided is for information purposes only and should not be considered as investment advice. The views, information, or opinions expressed in the text belong solely to the author, and not to the author’s employer, organization, committee or other group or individual or company.
Past performance is not indicative of future results.
High Risk Warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% and 75% of retail investor accounts lose money when trading CFDs with Tickmill UK Ltd and Tickmill Europe Ltd respectively. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Futures and Options: Trading futures and options on margin carries a high degree of risk and may result in losses exceeding your initial investment. These products are not suitable for all investors. Ensure you fully understand the risks and take appropriate care to manage your risk.
With 10 years of experience as a private trader and professional market analyst under his belt, James has carved out an impressive industry reputation. Able to both dissect and explain the key fundamental developments in the market, he communicates their importance and relevance in a succinct and straight forward manner.